Cleared Traditional

K211525 - SwiftNINJA Steerable Microcatheter

K211525 is the FDA 510(k) clearance for SwiftNINJA Steerable Microcatheter by Merit Medical Systems, Inc.. It is a Class 2 Cardiovascular device (product code KRA) cleared through the Traditional 510(k) pathway after a 60-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2021
Decision
60d
Days
Class 2
Risk

K211525 is an FDA 510(k) clearance for the SwiftNINJA Steerable Microcatheter. Classified as Catheter, Continuous Flush (product code KRA), Class II - Special Controls.

Submitted by Merit Medical Systems, Inc. (South Jordan, US). The FDA issued a Cleared decision on July 16, 2021 after a review of 60 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1210 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Merit Medical Systems, Inc. devices

Submission Details

510(k) Number K211525 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 17, 2021
Decision Date July 16, 2021
Days to Decision 60 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
65d faster than avg
Panel avg: 125d · This submission: 60d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KRA Catheter, Continuous Flush
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1210
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - KRA Catheter, Continuous Flush

All 127
Devices cleared under the same product code (KRA) and FDA review panel - the closest regulatory comparables to K211525.
Agile Devices Angler Steerable, Deflectable Microcatheter
K211110 · Agile Devices, Inc. · Jan 2022
PROWLER SELECT PLUS
K210838 · Medos International SARL · Aug 2021
Bullfrog Micro-Infusion Device
K210339 · Mercator Medsystems, Inc. · Aug 2021
Instylla Microcatheter 1.2
K210808 · Instylla, Inc. · Apr 2021
Rebar Micro Catheter
K210114 · Micro Therapeuatics, Inc. D/B/A Ev3 Neurovascular · Feb 2021
MAGIC Infusion Catheter
K202366 · Balt USA, LLC · Jan 2021